NXP Semiconductors N.V. Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? NXP Semiconductors N.V. Common Stock trades at $226.91 (market cap $58.27B), while Revolution Medicines Inc. Common Stock trades at $189.4 (market cap $40.32B). The key difference: NXP Semiconductors N.V. Common Stock is the larger of the two by market cap, and NXP Semiconductors N.V. Common Stock pays a 1.76% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NXP Semiconductors N.V. Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| NXPI | RVMD | |
|---|---|---|
Market Cap | $58.27B | $40.32B |
Volume | 3,950,702 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $332.67 | $221.15 |
52-Week Low | $184.19 | $47.50 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $66.38B | $37.02B |
Dividend Yield | 1.76% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.
Read more on NXPI →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →